Connection

Paula Traktman to Molecular Sequence Data

Back to Details
This is a "connection" page, showing publications Paula Traktman has written about Molecular Sequence Data.
Paula Traktman
Connection Strength
1.071
Molecular Sequence Data
  1. Functional characterization of the vaccinia virus I5 protein. Virol J. 2008 Dec 15; 5:148.
    View in: PubMed
    Score: 0.065
  2. The vaccinia virus gene I2L encodes a membrane protein with an essential role in virion entry. J Virol. 2008 Oct; 82(20):10247-61.
    View in: PubMed
    Score: 0.063
  3. Biochemical and genetic analysis of the vaccinia virus d5 protein: Multimerization-dependent ATPase activity is required to support viral DNA replication. J Virol. 2007 Jan; 81(2):844-59.
    View in: PubMed
    Score: 0.056
  4. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol Biol Cell. 2006 May; 17(5):2451-64.
    View in: PubMed
    Score: 0.053
  5. Genetic and cell biological characterization of the vaccinia virus A30 and G7 phosphoproteins. J Virol. 2005 Jun; 79(11):7146-61.
    View in: PubMed
    Score: 0.051
  6. Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions. J Virol. 2004 Aug; 78(16):8885-901.
    View in: PubMed
    Score: 0.048
  7. Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinase. J Virol. 2004 Feb; 78(4):1992-2005.
    View in: PubMed
    Score: 0.046
  8. Characterization of three paralogous members of the Mammalian vaccinia related kinase family. J Biol Chem. 2004 Feb 27; 279(9):7934-46.
    View in: PubMed
    Score: 0.045
  9. Genetic analysis of the vaccinia virus I6 telomere-binding protein uncovers a key role in genome encapsidation. J Virol. 2003 Oct; 77(20):10929-42.
    View in: PubMed
    Score: 0.045
  10. Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane. J Virol. 2003 Aug; 77(16):8857-71.
    View in: PubMed
    Score: 0.045
  11. The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase. J Virol. 2001 Dec; 75(24):12298-307.
    View in: PubMed
    Score: 0.040
  12. Clustered charge-to-alanine mutagenesis of the vaccinia virus A20 gene: temperature-sensitive mutants have a DNA-minus phenotype and are defective in the production of processive DNA polymerase activity. J Virol. 2001 Dec; 75(24):12308-18.
    View in: PubMed
    Score: 0.040
  13. Vaccinia virus telomeres: interaction with the viral I1, I6, and K4 proteins. J Virol. 2001 Nov; 75(21):10090-105.
    View in: PubMed
    Score: 0.039
  14. Elucidating the essential role of the A14 phosphoprotein in vaccinia virus morphogenesis: construction and characterization of a tetracycline-inducible recombinant. J Virol. 2000 Apr; 74(8):3682-95.
    View in: PubMed
    Score: 0.035
  15. Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis. J Virol. 2000 Mar; 74(5):2393-405.
    View in: PubMed
    Score: 0.035
  16. Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus I3 gene. J Virol. 1998 Apr; 72(4):2917-26.
    View in: PubMed
    Score: 0.031
  17. The vaccinia virus I1 protein is essential for the assembly of mature virions. J Virol. 1997 Dec; 71(12):9285-94.
    View in: PubMed
    Score: 0.030
  18. Vaccinia virus DNA replication: two hundred base pairs of telomeric sequence confer optimal replication efficiency on minichromosome templates. Proc Natl Acad Sci U S A. 1996 Sep 03; 93(18):9693-8.
    View in: PubMed
    Score: 0.028
  19. The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro. J Virol. 1995 Dec; 69(12):7823-34.
    View in: PubMed
    Score: 0.026
  20. Vaccinia virus DNA polymerase. In vitro analysis of parameters affecting processivity. J Biol Chem. 1994 Dec 09; 269(49):31190-7.
    View in: PubMed
    Score: 0.024
  21. Overexpression and purification of the vaccinia virus DNA polymerase. Protein Expr Purif. 1994 Aug; 5(4):409-21.
    View in: PubMed
    Score: 0.024
  22. Biochemical analysis of mutant alleles of the vaccinia virus topoisomerase I carrying targeted substitutions in a highly conserved domain. J Biol Chem. 1993 Jul 25; 268(21):15887-99.
    View in: PubMed
    Score: 0.022
  23. Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3'-5' exonuclease domain. J Virol. 1993 Jul; 67(7):4323-36.
    View in: PubMed
    Score: 0.022
  24. Vaccinia virus B1 kinase: phenotypic analysis of temperature-sensitive mutants and enzymatic characterization of recombinant proteins. J Virol. 1992 Jul; 66(7):4413-26.
    View in: PubMed
    Score: 0.021
  25. Characterization of vaccinia virus DNA replication mutants with lesions in the D5 gene. Chromosoma. 1992; 102(1 Suppl):S72-82.
    View in: PubMed
    Score: 0.020
  26. Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression. J Virol. 1992 Jan; 66(1):534-47.
    View in: PubMed
    Score: 0.020
  27. Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity. J Virol. 1991 Feb; 65(2):869-79.
    View in: PubMed
    Score: 0.019
  28. The enzymology of poxvirus DNA replication. Curr Top Microbiol Immunol. 1990; 163:93-123.
    View in: PubMed
    Score: 0.017
  29. Genetic evidence for involvement of vaccinia virus DNA-dependent ATPase I in intermediate and late gene expression. J Virol. 1989 Sep; 63(9):3999-4010.
    View in: PubMed
    Score: 0.017
  30. Molecular genetic analysis of vaccinia virus DNA polymerase mutants. J Virol. 1989 Feb; 63(2):841-6.
    View in: PubMed
    Score: 0.016
  31. Identification and characterization of the orf virus type I topoisomerase. Virology. 1995 Jan 10; 206(1):203-15.
    View in: PubMed
    Score: 0.006
  32. Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem. 1990 Dec 05; 265(34):20916-22.
    View in: PubMed
    Score: 0.005
  33. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 1990 Jun; 9(6):1805-13.
    View in: PubMed
    Score: 0.004
  34. Identification and DNA sequence of the Shope fibroma virus DNA topoisomerase gene. Virology. 1990 Jun; 176(2):439-47.
    View in: PubMed
    Score: 0.004
  35. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science. 1990 Jan 12; 247(4939):209-12.
    View in: PubMed
    Score: 0.004
  36. Vaccinia virus encodes an essential gene with strong homology to protein kinases. J Biol Chem. 1989 Dec 25; 264(36):21458-61.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.